Risk of first and second primary keratinocyte cancers in relation to treatment of rheumatoid arthritis with JAKi, TNFi, and non-TNFi bDMARDs-a Swedish nationwide study

Rheumatoid Arthritis
Do you want to read an article? Please log in or register.